Aligos Therapeutics Expands Executive Team
InvestingFeb 13 08:32 ET
Guerbet: Guerbet Strengthens Its Executive Committee With Two New Appointments to Accelerate Its Commercial and Industrial Development
Guerbet strengthens its Executive Committee with two new appointments to accelerate its commercial and industrial development Dan Raffi appointed Director of Commercial OperationsRaoul Bernhardt appoi
GlobeNewswireJul 10, 2023 11:48 ET
BMTC Group Reports Q1 2023 Results
BMTC Group (GBT.TO), together with its subsidiaries, manages and operates a retail network of furniture, household appliances, and electronic products in Canada, on Thursday reported its Q1 2023 resul
MT NewswiresJun 8, 2023 15:07 ET
BMTC Group Opens 11 New Stores In Quebec
BMTC Group (GBT.TO), together with its subsidiaries, manages and operates a retail network of furniture, household appliances, and electronic products in Canada, on Tuesday announced the expansion of
MT NewswiresMay 16, 2023 09:27 ET
BMTC Group Reports Q4 EPS of $0.36
07:36 AM EDT, 04/28/2023 (MT Newswires) -- BMTC Group (GBT.TO), together with its subsidiaries, manages and operates a retail network of furniture, household appliances, and electronic products in Can
MT NewswiresApr 28, 2023 07:43 ET
BMTC Group Reports Renewal of Normal Course Issuer Bid
06:08 AM EDT, 04/13/2023 (MT Newswires) -- BMTC Group (GBT.TO), together with its subsidiaries, manages and operates a retail network of furniture, household appliances, and electronic products in Can
MT NewswiresApr 13, 2023 06:10 ET
Guerbet: 2023 Strategic Priorities
2023 Strategic Priorities Diagnostic Imaging: increase EluciremTM sales and strengthen international positionsInterventional Imaging: prioritise Lipiodol sales with the development of innovative indic
GlobeNewswireJan 16, 2023 12:45 ET
BMTC Group Reports Lower Fiscal Q3 Profit, Revenue
08:15 AM EST, 12/15/2022 (MT Newswires) -- BMTC Group (GBT.TO), together with its subsidiaries, manages and operates a retail network of furniture, household appliances, and electronic products in Can
MT NewswiresDec 15, 2022 08:17 ET
White House Says It Will Continue To Monitor Developments On Cryptocurrencies
White House Says It Will Continue To Monitor Developments On Cryptocurrencies
Benzinga Real-time NewsNov 10, 2022 13:36 ET
Guerbet: Guerbet Announces a Change in Governance for Its Artificial Intelligence Projects
Guerbet announces a change in governance for its Artificial Intelligence projects Villepinte, November 3rd, 2022: Guerbet today announced an agreement with Merative, formalizing the termination of the
GlobeNewswireNov 3, 2022 13:05 ET
Guerbet: Revenue at September 30, 2022
Revenue on September 30, 2022 Faster growth in Q3 2022 Revenue: +5.1% at CER1 (€187 million)Very dynamic activity in Asia (+18.4%) and within MRI (+17.3%)Cumulative revenue at 9 months: +0.8% at CER
GlobeNewswireOct 20, 2022 11:51 ET
BioPharma Credit Receives $175 Million From Global Blood Therapeutics Investment
02:34 AM EDT, 10/06/2022 (MT Newswires) -- BioPharma Credit (BPCR.L) said Thursday that it received $175.4 million for its $132.5 million investment in a senior secured loan to biopharmaceutical compa
MT NewswiresOct 6, 2022 02:36 ET
Express News | News On Global Blood Therapeutics Inc. (GBT) Now Under PFE
Moomoo 24/7Oct 5, 2022 17:09 ET
Pfizer Completes Acquisition Of Global Blood Therapeutics >PFE
Pfizer Completes Acquisition Of Global Blood Therapeutics >PFE
Dow JonesOct 5, 2022 09:02 ET
Global Blood Therapeutics Expects to Complete Pfizer Deal in Early October
Global Blood Therapeutics (NASDAQ:GBT) expects to consummate its $5.4B deal with Pfizer (NYSE:PFE) on Oct. 5, the sickle cell disease drugmaker said in a regulatory filing on Friday. Pfizer (PFE) in e
Seeking AlphaSep 30, 2022 16:36 ET
Global Blood Therapeutics, Inc. (NASDAQ:GBT) Shares Purchased by Bank of America Corp DE
Bank of America Corp DE increased its stake in shares of Global Blood Therapeutics, Inc. (NASDAQ:GBT – Get Rating) by 16.8% during the 1st quarter, according to its most recent filing with the Secur
Defense WorldSep 27, 2022 04:21 ET
STOCKHOLDER ALERT: The M&A Class Action Firm Launches Merger Inquiry - RFP, SBTX, GBT, EVOP
PRNewswireSep 24, 2022 14:30 ET
Global Blood Therapeutics, Inc. (NASDAQ:GBT) Forecasted to Post FY2022 Earnings of ($4.55) Per Share
Global Blood Therapeutics, Inc. (NASDAQ:GBT – Get Rating) – Research analysts at Cantor Fitzgerald issued their FY2022 earnings estimates for shares of Global Blood Therapeutics in a research note
Defense WorldSep 24, 2022 02:01 ET
Global Blood Therapeutics (NASDAQ:GBT) Earns Neutral Rating From Cantor Fitzgerald
Cantor Fitzgerald reissued their neutral rating on shares of Global Blood Therapeutics (NASDAQ:GBT – Get Rating) in a research note issued to investors on Wednesday morning, PriceTargets.com reports
Defense WorldSep 24, 2022 01:11 ET
Guerbet Announces U.S. Food and Drug Administration (FDA) Approval of Elucirem™ (Gadopiclenol)
Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol) FDA approval of EluciremTM (NDA 216986) was granted after priority review, a designation assigned to appl
GlobeNewswireSep 21, 2022 13:05 ET
No Data
No Data